Encompass More Asset Management’s AbbVie ABBV Stock Holding History

Encompass More Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Sell	1,118 -25	-2%	-$5.38K	0.04%	229
2026 Q1	$249K	Sell	1,143 -103	-8%	-$22.8K	0.04%	213
2025 Q4	$285K	Buy	1,246 +17	+1%	+$3.87K	0.05%	202
2025 Q3	$284K	Sell	1,229 -210	-15%	-$42.8K	0.05%	187
2025 Q2	$267K	Sell	1,439 -51	-3%	-$9.48K	0.06%	170
2025 Q1	$312K	Sell	1,490 -61	-4%	-$11.9K	0.09%	148
2024 Q4	$276K	Sell	1,551 -6	-0.4%	-$1.1K	0.09%	157
2024 Q3	$308K	Buy	+1,557	New	+$291K	0.12%	134

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Encompass More Asset Management's ABBV Position: Q2 2026 in Review

Encompass More Asset Management reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $5.38K and leaving 1,118 shares worth $281K. The position accounts for 0.04% of the portfolio, ranked #229.

Encompass More Asset Management first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $312K in Q1 2025. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Encompass More Asset Management held 1,118 shares of AbbVie worth $281K as of Q2 2026.
Encompass More Asset Management sold 25 AbbVie shares in Q2 2026, an estimated $5.38K.
AbbVie made up 0.04% of Encompass More Asset Management's portfolio in Q2 2026, its #229 holding.
Encompass More Asset Management first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
Encompass More Asset Management's AbbVie position peaked at $312K in Q1 2025.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Encompass More Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.